Search the webpage

Created by Jenni J. Hakkarainen on  September 12, 2019  in category: News

ERM2019 attendees!

Experimentica’s poster evidently illustrating the effectivity of Aflibercept, administered systemically,  protection against the development of neovascular lesions - will be presented in today’s afternoon poster session.

And for the first time - a demonstration of convolutional neural network trained to recognize and quantify choroidal neovascularization lesion using Aiforia® Cloud.

 

LATEST NEWS

Refinement of the EAE Mouse Model

Experimental Autoimmune Encephalomyelitis (EAE) is used to study Multiple Sclerosis (MS) a chronic neuroinflammatory demyelinating disorder of the CNS. EAE ... Read More

Novel model for corneal permeability in vitro testing through the combined use of collagen-based hydrogels with stratified corneal epithelial cells

The cornea is critical for penetration of topically applied drugs into the eye. Assessment of the permeability properties of drug ... Read More

A synthetic metalloporphyrin SOD mimetic protects corneal epithelial cells from oxidative stress-induced damage in vitro and in vivo

Keratoconjunctivitis sicca (KCS) is a multifactorial disease of the lacrimal glands and ocular surface1. Pathological findings in patients with KCS ... Read More

Subscribe to Our Newsletter!

We promise that no sales pitches will be attached to newsletter. And don't worry, we hate spammers too!